Bioanalytical Services for Biotherapeutics and Small Molecules

Including Pharmacokinetics and Immunogenicity

Designed to be an extension of your laboratory, Nexelis, a Q² Solutions Company, supports bioanalysis in all phases with agile assay development to validation mindset. Whether we design a custom bioanalytical assay or support a client’s technology transfer, our method development process results in an optimized assay compliant with global standards. Our organization commits to continued investment and development in bioanalytical methods. Clients in the pharmaceutical, biotech, and animal health industries rely on us for the complete range of comprehensive bioanalytical services for all modalities.

From discovery bioanalysis to regulated bioanalytical work at our U.S. location in Indianapolis and our partner lab in Beijing, China, Nexelis provides a superior level of experience and scientific expertise. Here, you have access to leading scientific experts in liquid chromatography-mass spectrometry (LC-MS), high resolution LC-MS, ligand binding assays (LBA), and immunogenicity assays — including anti-drug antibody (ADA) and cell-based neutralizing antibody (nAb) assays. We have worked with over 80 different matrices across numerous species from biological fluids and tissues to cell media, with the capacity to scale to clinical.